News

Erick Romero Quintana, 22, described by law enforcement as one of the biggest social media influencers in the Southern ...
The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.
Under the control of anti-vaccine advocate Robert F. Kennedy Jr., the Food and Drug Administration is unilaterally terminating universal access to seasonal COVID-19 vaccines; instead, only people ...
In fact, the Food and Drug Administration 20 years ago raised questions about whether it truly works, as well as its potential to cause cancer. But the agency never acted on its own concerns.
Following the Trump administration’s recent executive orders on drug pricing, one in April (summarized here) and one the same day as the guidance, this draft guidance is the first substantive ...
In the U.S., there is no central government body deciding what drugs, after the Food and Drug Administration determines they’re safe, can be sold and at what price. Prices are instead negotiated ...
May 14 (Reuters) - The U.S. Food and Drug Administration has approved AbbVie's (ABBV.N), opens new tab drug to treat adults with a type of lung cancer who have received previous treatment ...
WASHINGTON, DC - OCTOBER 06: Activists protest the price of prescription drug costs in front of the ... More U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in ...
The president was flanked by Kennedy, Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz, Food and Drug Administration commissioner Dr. Marty Makary and National Institutes of ...
Funding from the U.S. National Institutes of Health contributed to all but two of the 356 drugs approved by the Food and Drug Administration from 2010 to 2019, according to a Bentley University study.
The US Food and Drug Administration (FDA) and OpenAI have reportedly been discussing a potential partnership that seeks to use artificial intelligence in drug evaluations of the agency.
OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the ...